Your shopping cart is currently empty

3-(1-Carboxyvinyloxy)benzoic acid is a dual enzymatic inhibitor of MbtI from Mycobacterium tuberculosis and arginine synthase from Serratia marcescens, exhibiting Ki values of 500 μM and 3.2 μM respectively, 3-(1-Carboxyvinyloxy)benzoic acid display measurable antibacterial activity that supports its application as a mechanistic probe and lead compound for anti-infective and antimicrobial drug discovery research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $107 | - | In Stock | |
| 5 mg | $263 | - | In Stock | |
| 10 mg | $423 | - | In Stock | |
| 25 mg | $848 | - | In Stock | |
| 50 mg | $1,350 | - | In Stock | |
| 100 mg | $2,170 | - | In Stock |
| Description | 3-(1-Carboxyvinyloxy)benzoic acid is a dual enzymatic inhibitor of MbtI from Mycobacterium tuberculosis and arginine synthase from Serratia marcescens, exhibiting Ki values of 500 μM and 3.2 μM respectively, 3-(1-Carboxyvinyloxy)benzoic acid display measurable antibacterial activity that supports its application as a mechanistic probe and lead compound for anti-infective and antimicrobial drug discovery research. |
| Molecular Weight | 208.17 |
| Formula | C10H8O5 |
| Cas No. | 16929-37-6 |
| Smiles | O=C(O)C(OC1=CC=CC(=C1)C(=O)O)=C |
| Storage | store at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.